Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1517, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin dominates for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 539, 2007-01 ,pp. :
Access to resources
Recommend
Short-course antibacterials beneficial in CAP
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :
Moxifloxacin tops in CAP regardless of resistance level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
Moxifloxacin monotherapy on par with combination therapy in CAP
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
Moxifloxacin: sequential therapy produces rapid improvements in CAP
Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. :